Definitive Contract HDTRA113C0072

This is a $499,792 definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to Emory University, a private research university in Atlanta, Georgia. The contract is for the development and refinement of pre-clinical models of infectious diseases, with a focus on small animal models, non-human primate models, animal replacement models, and non-traditional animal models. The contract enables Emory to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of candidate countermeasures such as therapeutics, vaccines, and diagnostics against a wide range of infectious agents, including those with pandemic potential and drug-resistant pathogens. This contract is not designated as a set-aside. Emory University is the prime contractor, and Saint Louis University is a major subcontractor, providing expertise in areas such as radiology and medical education. This contract contributes to DTRA's efforts to advance the development of medical countermeasures against infectious diseases.